ArticleThe Lancet. Oncology2022

MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study.

Behfar Ehdaie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.